Summary
Further key aspects of the report:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Antihemophilic Factor market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Antihemophilic Factor market segmented into
Recombinant Factor VIII
Plasma-derived Factor VIII
Based on the end-use, the global Antihemophilic Factor market classified into
Hospital
Pharmacy
Based on geography, the global Antihemophilic Factor market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Shire (Baxter)
Bayer
CSL
Pfizer
Grifols
Biogen
Octapharma
NovoNordisk
Greencross
Kedrion
BPL
Hualan Bio
RAAS
End of Summary
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL ANTIHEMOPHILIC FACTOR INDUSTRY
2.1 Summary about Antihemophilic Factor Industry
2.2 Antihemophilic Factor Market Trends
2.2.1 Antihemophilic Factor Production & Consumption Trends
2.2.2 Antihemophilic Factor Demand Structure Trends
2.3 Antihemophilic Factor Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Recombinant Factor VIII
4.2.2 Plasma-derived Factor VIII
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospital
4.3.2 Pharmacy
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Recombinant Factor VIII
5.2.2 Plasma-derived Factor VIII
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospital
5.3.2 Pharmacy
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Recombinant Factor VIII
6.2.2 Plasma-derived Factor VIII
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospital
6.3.2 Pharmacy
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Recombinant Factor VIII
7.2.2 Plasma-derived Factor VIII
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospital
7.3.2 Pharmacy
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Recombinant Factor VIII
8.2.2 Plasma-derived Factor VIII
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospital
8.3.2 Pharmacy
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Recombinant Factor VIII
9.2.2 Plasma-derived Factor VIII
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospital
9.3.2 Pharmacy
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Shire (Baxter)
10.1.2 Bayer
10.1.3 CSL
10.1.4 Pfizer
10.1.5 Grifols
10.1.6 Biogen
10.1.7 Octapharma
10.1.8 NovoNordisk
10.1.9 Greencross
10.1.10 Kedrion
10.1.11 BPL
10.1.12 Hualan Bio
10.1.13 RAAS
10.2 Antihemophilic Factor Sales Date of Major Players (2017-2020e)
10.2.1 Shire (Baxter)
10.2.2 Bayer
10.2.3 CSL
10.2.4 Pfizer
10.2.5 Grifols
10.2.6 Biogen
10.2.7 Octapharma
10.2.8 NovoNordisk
10.2.9 Greencross
10.2.10 Kedrion
10.2.11 BPL
10.2.12 Hualan Bio
10.2.13 RAAS
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
List of Tables and Figures
List of Table
Table Antihemophilic Factor Product Type Overview
Table Antihemophilic Factor Product Type Market Share List
Table Antihemophilic Factor Product Type of Major Players
Table Brief Introduction of Shire (Baxter)
Table Brief Introduction of Bayer
Table Brief Introduction of CSL
Table Brief Introduction of Pfizer
Table Brief Introduction of Grifols
Table Brief Introduction of Biogen
Table Brief Introduction of Octapharma
Table Brief Introduction of NovoNordisk
Table Brief Introduction of Greencross
Table Brief Introduction of Kedrion
Table Brief Introduction of BPL
Table Brief Introduction of Hualan Bio
Table Brief Introduction of RAAS
Table Products & Services of Shire (Baxter)
Table Products & Services of Bayer
Table Products & Services of CSL
Table Products & Services of Pfizer
Table Products & Services of Grifols
Table Products & Services of Biogen
Table Products & Services of Octapharma
Table Products & Services of NovoNordisk
Table Products & Services of Greencross
Table Products & Services of Kedrion
Table Products & Services of BPL
Table Products & Services of Hualan Bio
Table Products & Services of RAAS
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Antihemophilic Factor Market Forecast (Million USD) by Region 2021f-2026f
Table Global Antihemophilic Factor Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Antihemophilic Factor Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Antihemophilic Factor Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
Figure Global Antihemophilic Factor Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Antihemophilic Factor Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Antihemophilic Factor Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Antihemophilic Factor Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Antihemophilic Factor Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Antihemophilic Factor Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Antihemophilic Factor Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Recombinant Factor VIII Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Plasma-derived Factor VIII Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Recombinant Factor VIII Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Plasma-derived Factor VIII Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Recombinant Factor VIII Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Plasma-derived Factor VIII Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Recombinant Factor VIII Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Plasma-derived Factor VIII Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Recombinant Factor VIII Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Plasma-derived Factor VIII Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Recombinant Factor VIII Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Plasma-derived Factor VIII Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pharmacy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Antihemophilic Factor Sales Revenue (Million USD) of Shire (Baxter) 2017-2020e
Figure Antihemophilic Factor Sales Revenue (Million USD) of Bayer 2017-2020e
Figure Antihemophilic Factor Sales Revenue (Million USD) of CSL 2017-2020e
Figure Antihemophilic Factor Sales Revenue (Million USD) of Pfizer 2017-2020e
Figure Antihemophilic Factor Sales Revenue (Million USD) of Grifols 2017-2020e
Figure Antihemophilic Factor Sales Revenue (Million USD) of Biogen 2017-2020e
Figure Antihemophilic Factor Sales Revenue (Million USD) of Octapharma 2017-2020e
Figure Antihemophilic Factor Sales Revenue (Million USD) of NovoNordisk 2017-2020e
Figure Antihemophilic Factor Sales Revenue (Million USD) of Greencross 2017-2020e
Figure Antihemophilic Factor Sales Revenue (Million USD) of Kedrion 2017-2020e
Figure Antihemophilic Factor Sales Revenue (Million USD) of BPL 2017-2020e
Figure Antihemophilic Factor Sales Revenue (Million USD) of Hualan Bio 2017-2020e
Figure Antihemophilic Factor Sales Revenue (Million USD) of RAAS 2017-2020e